"

According to the latest report published by Data Bridge Market Research, the Next Generation Sequencing (NGS) Market

CAGR Value

• The global next generation sequencing (NGS) market was valued at USD 15.98 billion in 2024 and is expected to reach USD 49.21 billion by 2032
• During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 15.10%, primarily driven by continuous advancements in sequencing technologies and increasing clinical applications

The Next Generation Sequencing (NGS) Marketdocument identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the market. This Next Generation Sequencing (NGS) Market report performs comprehensive analysis of profiles of key market players that gives a competitive landscape to the businesses. Besides this, market drivers, market restraints, opportunities and challenges are evaluated under market overview which gives valuable insights to businesses for taking right moves. The report comprises of precise and up to date information about the consumer’s demands, their preferences, and their variable likings about particular product. No stone is left unturned about the market research analysis while generating and presenting this Next Generation Sequencing (NGS) Market research report to the clients which satisfies their anticipation.

Stay informed with our latest keyword market research covering strategies, innovations, and forecasts. Download full report: https://www.databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market

Next Generation Sequencing (NGS) Market Segmentation and Market Companies

Segments

• On the basis of products and services, the global next generation sequencing (NGS) market is segmented into pre-sequencing products and services, NGS platforms, consumables, services for data analysis, and storage.
• Based on the technology, the market is categorized into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and others.
• By application, the market is divided into diagnostics, drug discovery, precision medicine, agricultural and animal research, and others.
• Considering end-user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

Market Players

• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Qiagen
• Roche
• Pacific Biosciences of California, Inc.
• F. Hoffmann-La Roche Ltd